Mitochondrial and endoplasmic reticulum stress pathways cooperate in zearalenone-induced apoptosis of human leukemic cells
© Banjerdpongchai et al; licensee BioMed Central Ltd. 2010
Received: 26 October 2010
Accepted: 30 December 2010
Published: 30 December 2010
Zearalenone (ZEA) is a phytoestrogen from Fusarium species. The aims of the study was to identify mode of human leukemic cell death induced by ZEA and the mechanisms involved.
Cell cytotoxicity of ZEA on human leukemic HL-60, U937 and peripheral blood mononuclear cells (PBMCs) was performed by using 3-(4,5-dimethyl)-2,5-diphenyl tetrazolium bromide (MTT) assay. Reactive oxygen species production, cell cycle analysis and mitochondrial transmembrane potential reduction was determined by employing 2',7'-dichlorofluorescein diacetate, propidium iodide and 3,3'-dihexyloxacarbocyanine iodide and flow cytometry, respectively. Caspase-3 and -8 activities were detected by using fluorogenic Asp-Glu-Val-Asp-7-amino-4-methylcoumarin (DEVD-AMC) and Ile-Glu-Thr-Asp-7-amino-4-methylcoumarin (IETD-AMC) substrates, respectively. Protein expression of cytochrome c, Bax, Bcl-2 and Bcl-xL was performed by Western blot. The expression of proteins was assessed by two-dimensional polyacrylamide gel-electrophoresis (PAGE) coupled with LC-MS2 analysis and real-time reverse transcription polymerase chain reaction (RT-PCR) approach.
ZEA was cytotoxic to U937 > HL-60 > PBMCs and caused subdiploid peaks and G1 arrest in both cell lines. Apoptosis of human leukemic HL-60 and U937 cell apoptosis induced by ZEA was via an activation of mitochondrial release of cytochrome c through mitochondrial transmembrane potential reduction, activation of caspase-3 and -8, production of reactive oxygen species and induction of endoplasmic reticulum stress. Bax was up regulated in a time-dependent manner and there was down regulation of Bcl-xL expression. Two-dimensional PAGE coupled with LC-MS2 analysis showed that ZEA treatment of HL-60 cells produced differences in the levels of 22 membrane proteins such as apoptosis inducing factor and the ER stress proteins including endoplasmic reticulum protein 29 (ERp29), 78 kDa glucose-regulated protein, heat shock protein 90 and calreticulin, whereas only ERp29 mRNA transcript increased.
ZEA induced human leukemic cell apoptosis via endoplasmic stress and mitochondrial pathway.
The phytoestrogen zearalenone (ZEA) is one of the most active naturally occurring estrogenic compounds [1, 2]. Food, snacks, dried fruits, dried vegetables and beverages such as beer, often contain ZEA [3–5]. The average daily intake of ZEA in adults ranges from 0.8-29 ng/kg body weight (b.w.)/day, while small children have a higher average daily intake, 6-55 ng/kg b.w./day .
Treatment with Zea (10-40 μM) of Vero, Caco-2 and DOK cells results in apoptosis as evidenced by DNA ladder formation and presence of apoptotic bodies . Recently, ZEA has been shown to induce apoptosis in human hepatocytes (HepG2) via p53-dependent mitochondrial signaling pathway with the up regulation of ATM and GADD45 involved in DNA repair .
In mammalian cells, there are two major pathways involved in apoptosis: mitochondria-initiated intrinsic pathway and death receptor-stimulated extrinsic pathway [9–11]. In the former pathway, proapoptotic signals provoke release from mitochondrial inter-membranous space into cytosol of cytochrome c, which forms a complex with Apaf-1 and dATP, known as apoptosome, and triggers caspase-9 activation. Activation of caspase-9 leads to subsequent activation of executioner caspases, such as caspase-3, -6, -7, which in turn stimulates a series of apoptotic events, eventually leading to cell death [9, 12, 13]. The extrinsic pathway begins with binding of Fas ligand to Fas death receptor, and an adaptor molecule is recruited to the receptor, which allows binding and proteolytic activation of caspase-8. Activated caspase-8 then cleaves effector caspase-3, -6 and -7, leading to apoptotic cell death [10, 12, 14].
In addition to the above mentioned pathways, apoptosis can be induced via endoplasmic reticulum (ER), which normally regulates protein synthesis and intracellular calcium (Ca2+) homeostasis . Excessive ER stress triggers apoptosis through a variety of mechanisms including redox imbalance, alteration in Ca2+ level and activation of Bcl-2 family proteins .
Calreticulin (CRT) is an abundant Ca2+-binding chaperone, which is mostly present in ER lumen, although it can also be found in other subcellular localizations [17, 18]. When present on the surface of damaged cells, it can serve as an 'eat-me' signal and hence facilitates the recognition and later engulfment of dying cells by macrophages  or by dendritic cells . It is thought that this function determines the immunostimulatory effect of CRT, as presentation of tumor antigens by dendritic cells is required for the immunogenic effect of anthracyclin-treated cancer cells [20–22]. Alternatively, CRT may bind tumor antigenic peptides and facilitate their efficient presentation to T cells . Crosstalk with the two well-characterized apoptotic pathways also exists, since ER stress can also activate caspase-8 and caspase-9 [24, 25].
The ability of ZEA to modulate leukemic cell growth has not yet been well characterized. Using two human leukemic HL-60 and U937 cell lines we found that human leukemic cell apoptosis induced by ZEA was related to caspase-3 and -8 activation, mitochondrial transmembrane potential (MTP) reduction and cytochrome c release. ZEA also induced oxidative stress via ROS generation, Bax upregulation and Bcl-xL downregulation. The mechanistic effect also involved increased Ca2+ concentration in cytosol and mitochondria indicating ER stress but there was no calreticulin exposure on the cell surface at 30 min. Two-dimensional gel-electrophoresis of proteins following 24 h treatment revealed upregulated expression of ER-mediated chaperone endoplasmic reticulum protein 29 (ERp29), 78 kDa glucose regulated protein (GRP78), and calreticulin supporting the involvement of ER stress.
Materials and methods
Chemicals and test media
Human promyelocytic leukemic HL-60 and human promonocytic U937 cells were gifts from Dr. Sukhathida Ubol and Dr. Watchara Kasinroek. The cells were cultured in 10% fetal bovine serum in RPMI-1640 medium supplemented with penicillin G (100 units/ml) and streptomycin (100 μg/ml) at 37°C in a humidified atmosphere containing 5% CO2. The human leukemic cells (1 × 106) were treated with ZEA at indicated concentration and duration. ZEA was dissolved in DMSO as a vehicle and the maximal volume used was not exceeded 10 μl/ml of media.
The blood was obtained from adult volunteers with IRB approval. Peripheral blood mononuclear cells (PBMCs) were isolated from heparinized blood by density gradient centrifugation using lymphoprep according to standard protocols. Cells were cultured in RPMI-1640 medium supplemented with 10% heat-inactivated fetal bovine serum, 2 mM glutamine, 100 U/ml penicillin and 100 μg/ml streptomycin. PBMCs (3 × 106) were treated with ZEA at indicated concentration and duration.
Following ZEA treatment, cell viability was assessed by MTT (3-(4,5-dimethyl)-2,5-diphenyl tetrazolium bromide) assay . This method is based on the ability of viable cells to reduce MTT and form a blue formazan product. MTT solution (sterile stock solution of 5 mg/ml) was added to cell suspension at a final concentration of 100 μg/ml and the solution incubated for 4 h at 37°C in a humidified 5% CO2 atmosphere. The medium was then removed and cells were treated with DMSO for 30 min. The optical density of the cell lysate was measured at 540 nm with reference wavelength of 630 nm using microtiter plate reader (Biotek, USA). Number of viable cells was calculated from untreated cells, and the data were expressed as percent cell viability.
Determination of mitochondrial transmembrane potential and ROS production
For measurement of mitochondrial membrane potential and intracellular ROS, either 40 nM 3,3'-dihexyloxacarbocyanine iodide (for mitochondrial transmembrane potential determination) or 5 μM 2',7'-dichlorofluorescein diacetate (for ROS detection) were added for 15 min at 37°C and the cells are then subjected to flow cytometry.
For flow cytometric assessment of DNA fragmentation and cell cycle distribution, 1 × 106 cells were harvested and re-suspended in a solution containing PI (50 μg/ml), 0.1% Triton X-100 and 0.1% sodium citrate in PBS. Cells then were analyzed in a FACScan equipped with a 488 nm argon laser using CellQuest software (Becton-Dickinson, USA). Data were depicted as histograms and the percentage of cells displaying hypodiploid DNA content was indicated. Percentage of cells in each phase was also evaluated to determine the existence of cell cycle arrest.
Assay of caspase-3 and caspase-8 activity
Cleavage of the fluorogenic peptide substrates DEVD-AMC and IETD-AMC, indicative of caspase-3-like and caspase-8-like enzyme activity, was estimated. Cell lysates (1 × 106 cells) and substrate (50 μM) were combined in a standard reaction buffer and added to a 96-well plate. Enzyme-catalyzed release of AMC was measured by a fluorescence plate reader (Bio-tek, USA) using 355 nm excitation and 460 nm emission wavelengths.
Two-dimensional polyacrylamide gel-electrophoresis (2-D PAGE)
U937 cells, treated and untreated with 20 μM ZEA for 4 and 24 h were harvested and washed twice and the cell precipitates were used further. Albumin was first removed using ProteoExtract Albumin/Removal kit. The amount of protein loaded in 2-D PAGE was 200 μg/gel. 2-D PAGE was performed using the immobiline/polyacrylamide system. Samples were applied by overnight in-gel rehydration of 70 mm nonlinear pH 3-10 IPG gel strips. The first dimension (IEF) was performed at 6500 Vh for 3.5 h, using a Pharmacia LKB Multiphor II system. IPG strips were equilibrated with buffer in two steps. The first step employed 50 mM Tris-HCl buffer, pH 6.8, 6 M urea, 30% glycerol, 1% SDS, and 1% DTT, while 2.5% iodoacetamide replaced DTT in the second step. Then IPG strips were applied to the second-dimension 12.5% T SDS polyacrylamide gels (100 mm × 105 mm × 1.5 mm). Electrophoresis was performed in a Hoefer system at 20 mA for 2.5 h at room temperature. After electrophoresis, proteins were visualized by CBR-250 staining.
PAGE of plasma membrane proteins
ProteoPrep Universal Protein Extraction kit was used to isolate membrane and cytosolic proteins from HL-60 cell line. The cytoplasmic extraction reagent was added to the cell pellet and the sample was sonicated at 4°C and centrifuged at 14,000 × g for 45 min. The supernatant was collected. The same reagent was added to the remaining pellet, followed by sonication and centrifugation, and the resulting supernatant was pooled with that obtained earlier. The pooled supernatant was dried using Speed Vac. The dried sample was resuspended in the soluble protein resuspension reagent (Sup1).
The precipitate was resuspended in cellular and organelle membrane solubilizing reagent. The sample was centrifuged at 14,000 × g for 45 min at 15°C. The supernatant was collected as Sup2. Sup1 and 2 were treated with 5 mM tributylphosphine (TBP) (reduction) for 1 h at room temperature, then 15 mM iodoacetamide (alkylation) was added and the reaction mixture was incubated for 1.5 h. The reaction was stopped by adding TBP and incubated for 15 min. The sample was centrifuged at 20,000 × g for 5 min at room temperature and the clear supernatant was collected. The concentrations of proteins in Sup1 and Sup2 were measured using the Bradford method. Samples were prepared for 2-D PAGE by adding ampholine and solubilizing reagent to adjust the volume.
2-D PAGE was performed using the immobiline/polyacrylamide system. Samples were applied by overnight in-gel rehydration of 70 mm nonlinear pH 3-10 IPG gel strips. The first dimension electrophoresis (IEF) was performed as described for U937 cells.
Tryptic in-gel digestion of protein spots
Differential expression of proteomic profiles in treated and untreated cell lines were compared. Spots of interest were excised and transferred to 1.5 ml tubes. A 50 μl aliquot of 0.1 M NH4HCO3 in 50% acetonitrile was added, and the gel was incubated for 20 min at 30°C. The solvent was discarded and the gel particles were dried completely. Reduction and alkylation was performed by swelling the gel pieces in 50 μl buffer solution (0.1 M NH4HCO3, 10 mM DTT, and 1 mM EDTA) and incubating at 60°C for 45 min. Then the excess liquid was removed and quickly replaced by the same volume of freshly prepared 100 mM iodoacetamide in 0.1 M NH4HCO3 solution. The gel suspension was incubated at room temperature in the dark for 30 min and iodoacetamide solution removed. Each gel piece was washed with 50% acetonitrile in water 3 times for 10 min, and completely dried. A 50 μl aliquot of digestion buffer (0.05 M Tris HCl, 10% acetonitrile, 1 mM CaCl2, pH 8.5) and 1 μl aliquot of trypsin (1 mg trypsin in 10 μl 1% acetic acid) were added to the gel pieces. The mixtures were incubated at 37°C overnight. The digestion buffer was removed and saved. The gel pieces were then extracted by adding 60 μl of 2% freshly prepared trifluoroacetic acid and incubating for 30 min at 60°C. The extract and saved digestion buffer were pooled and dried. Digested peptides were dissolved in 6 μl of 0.1% formic acid for MS/MS injection.
Protein identification by LC-MS/MS
LC-MS/MS analyses were carried out using a capillary LC system (Waters, UK) coupled to a Q-TOF mass spectrometer (Micromass, Manchester, UK) equipped with a Z-spray ion-source working in the nanoelectrospray mode. Glu-fibrinopeptide was used to calibrate the instrument in MS/MS mode. Tryptic peptides were concentrated and desalted on a 75 μm ID × 150 mm C18 PepMap column (LC Packings, Amsterdam, The Netherlands). Eluent A and B was 0.1% formic acid in 97% water, 3% acetonitrile and 0.1% formic acid in 97% acetonitrile respectively. Six μl of sample were injected into the nanoLC system, and separation was performed using the following gradient: 0 min 7% eluent B, 35 min 50% B, 45 min 80% B, 49 min 80% B, 50 min 7% B, 60 min 7% B. Database search was performed with ProteinLynx screening SWISS-PROT and NCBI. For proteins that were difficult to find, Mascot search tool available on the Matrix Science site screening NCBInr was used.
Gel scanning and image analysis
Stained gels were scanned using an ImageScanner II (GE Healthcare, Uppsala, Sweden) and ImageMaster™(GE Healthcare, Uppsala, Sweden) was used for computer analysis.
Flow cytometric analysis of cell surface calreticulin
HL-60 cells were plated in 24-well plates and incubated for the indicated time. Cells were harvested, washed twice with PBS and incubated for 30 min with primary antibody, diluted in cold blocking buffer (2% FBS in PBS), followed by washing and incubation for 30 min with the FITC-conjugated monoclonal secondary antibody diluted 1:500 in blocking buffer. Each sample was then analyzed by FACScan (Becton Dickinson, USA) to identify cell surface calreticulin. Isotype matched IgG antibodies were used as control, and the fluorescence intensity of stained cells was gated on PI-negative cells.
Western blot analysis
To obtain a cytosolic-rich fraction, ZEA-treated cells were harvested and washed once in ice cold PBS and incubated at 4°C for 10 min with ice-cold cell lysis buffer (250 mM sucrose, 70 mM KCl, 0.25% Triton X-100, 100 μM PMSF, 1 mM DTT in PBS with complete mini protease inhibitor cocktail). The cell suspension was centrifuged at 20,000 × g for 20 min. The supernatant was collected as the cytosolic-rich fraction. Protein concentration of the cytosolic-rich fraction was determined by the Bradford method. Cytosolic proteins (50 μg) were separated by 17% SDS-PAGE and transferred onto nitrocellulose membranes. After treating with 5% non-fat milk in TBS containing 0.2% Tween-20 (blocking buffer), membranes were incubated with mouse monoclonal antibodies to cytochrome c, Bax and Bcl-2 and rabbit polyclonal antibody to Bcl-xL. For detection, appropriate horseradish peroxidase (HRP) conjugated secondary antibodies were used at 1:20,000 dilution. Protein bands were visualized on X-ray film with SuperSignal West Pico Chemiluminecent Substrate.
FACS analysis for cytosolic and mitochondrial Ca2+ levels
Cytosolic Ca2+ levels were determined using the fluorescence dye 1 μM Fluo3-AM in FITC setting. Mitochondrial Ca2+ levels were determined using the fluorescent dye 250 nM Rhod2-AM in PE setting. After treatment with ZEA for 4 h, cells were incubated with fluorescent dye for 15 min at 37°C, and washed with PBS containing 10 mM glucose and analyzed immediately by flow cytometry. In each analysis, 10,000 events were recorded and analyzed by FACScan (Becton Dickinson, USA).
RNA extraction and gene expression analysis
Primer Sequences Used for Real-time Reverse Transcription Polymerase Chain Reaction.
GenBank accession number
Results were expressed as mean ± SEM (standard error of mean). Statistical difference between control and treated group was determined by the one-way ANOVA (Kruskal Wallis analysis) at limit of p < 0.05 in triplicate of three independent experiments. For comparison between two groups, data were analyzed using Student's t-test.
Cell cytotoxicity with apoptotic induction
Mitochondria involvement in ZEA-induced HL-60 and U937 cell apoptosis
Expression of Bax, Bcl-2 and Bcl-xL in ZEA-treated HL-60 cells
ROS production of ZEA on human leukemic cells
Effect of ZEA on activities of caspase-3 and -8 in HL-60 and U937 cells
Protein expression in ZEA-treated U937 and HL-60 cells
Identified Plasma Membrane Protein Spots in 24 h ZEA-treated HL-60 Cells by LC/MS/MS.
*Expression in treated cells (folds)
Transitional endoplasmic reticulum ATPase
Glial fibrillary acidic protein
Keratin, type II cytoskeletal 8
Heat shock protein HSP 90-alpha
78 kDa glucose-regulated protein precursor (GRP 78)
L-plastin, Lymphocyte cytosolic protein 1
Protein disulfide isomerase precursor
Elongation factor 2
unnamed protein product
Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial
T-complex protein 1 subunit gamma
T-complex protein 1 subunit zeta
chaperonin containing TCP1, subunit 6A isoform a
apoptosis inducing factor like isoform CRA d Homo sapiens
RING finger protein 112
catalase [Homo sapiens]
unnamed protein product
Sorting and assembly machinery component 50 homolog
unnamed protein product
spectrin domain with coiled coils 1 isoform CRA d Homo sapiens
ATP synthase subunit gamma, mitochondrial
Tropomyosin alpha-3 chain
Epidermal growth factor receptor kinase substrate 8-like protein 1
ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1
L-lactate dehydrogenase B chain
AF4/FMR2 family member 4
Podocalyxin like protein 1 precursor
immunoglobulin A heavy chain variable region Homo sapiens
tRNA guanosine-2'-O-methyltransferase TRM13 homolog
UPF0614 protein C14orf102
Suppressor of cytokine signaling 4
Keratin, type II cytoskeletal 1(CK-1)
Keratin, type II cytoskeletal 7 (CK-7)
unnamed protein product [Homo sapiens]
nebulette Homo sapiens
Endoplasmic reticulum protein ERp29
ATP synthase subunit d, mitochondrial
unnamed protein product
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10
unnamed protein product
Activating signal cointegrator 1 complex subunit 1
NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial
ER stress gene expression at mRNA levels
Cytosolic and mitochondrial Ca2+status in ZEA-treated leukemic cells
Effect of ZEA treatment on calreticulin exposure on cell surface
ZEA is a non-steroidal estrogenic mycotoxin produced as a secondary metabolite by several fungi of the genus Fusarium [38, 39]. In the present study, ZEA induced apoptosis in human leukemic HL-60 and U937 cell lines, but less in PBMCs, as evidenced by presence of apoptotic bodies and cells with subdiploid peaks (representing DNA fragmentation). ZEA is cytotoxic to bovine lymphocytes  and induces human PBMC apoptosis and necrosis depending on the concentrations of ZEA .
Two central pathways have been shown to be involved in the process of apoptotic cell death: one is the death receptor pathway with direct involvement of caspase-8 and the other is the mitochondrial pathway in which cytochrome c is released from mitochondria into cytosol. Data presented here suggest that mitochondrial dysfunction is the mechanism involved in ZEA-induced apoptotic death in human leukemic cells. ZEA targets mitochondria and/or lysosomes and induces lipid peroxidation (indicating oxidative stress) and cell death in human colon Caco-2 cell line . The loss of mitochondrial transmembrane potential and the increase of ROS generation were early events caused by ZEA. The following two possibilities are proposed: (i) ZEA increases ROS production which leads to mitochondrial dysfunction; (ii) Mitochondrial dysfunction is induced by ZEA treatment and results in ROS generation.
Bax, a pro-apoptotic protein in Bcl-2 family, was upregulated indicating the involvement of mitochondria, as Bax forms channels at the outer mitochondrial membrane to facilitate the release of cytochrome c [43, 44]. Activation of mitochondrial permeability transition is required for the complete release of cytochrome c [45, 46]. The increased ratios of Bax/Bcl-2 and Bax/Bcl-xL in ZEA-treated human leukemic cells would facilitate this process. It has been recently reported that ZEA-induced human hepatoma HepG2 cell apoptosis also involves mitochondrial alterations including Bax relocalization into the mitochondrial outer membrane, loss of mitochondrial transmembrane potential, permeability transition pore complex opening, ROS production and cytochrome c release .
Proteomic profiling of ZEA-treated and untreated U937 cells revealed a role of enzymes in carbohydrate and nucleotide metabolism in apoptosis. Besides its role in glycolysis, GAPDH initiates a cell death cascade . Diverse apoptotic stimuli activate inducible nitric oxide synthase (iNOS) or neuronal NOS (nNOS), with the NO S-nitrosylating GAPDH, abolishing its catalytic activity and conferring on it the ability to bind to Siah1, an E3-ubiquitin-ligase with a nuclear localizing signal. The GAPDH-Siah1 protein complex, in turn, translocates to the nucleus and mediates cell death.
The involvement of ER stress in ZEA-induced apoptosis shown in this study led to an investigation of CRT, an ER-resident stress-regulated chaperone with C-terminal KDEL signal [48, 49]. Under certain circumstances, ER dysfunction leads to an accumulation of unfolded or misfolded proteins in the ER lumen and activates compensatory mechanism, which has been referred to as ER stress response or unfolded protein response . Several ER transmembrane proteins are identified as sensors of ER stress. These include pancreatic ER kinase (PERK), inositol requiring enzyme 1 (IRE1) and activating transcription factor 6 (ATF6). PERK phosphorylates the alpha subunit of eukaryotic initiation factor 2 (eIF2alpha), which attenuates the initiation of translation in response to ER stress. The activation of IRE1 and ATF6 signaling promotes pro-apoptotic transcription factor CHOP and the expression of ER-localized chaperones, such as CRT, GRP78 and GRP94, which facilitate the restoration of proper protein folding within the ER . These protective responses result in an overall decrease in translation, enhanced protein degradation and increased levels of ER chaperones, which consequently increase the protein folding capacity of the ER. However, sustained ER stress ultimately leads to decreased ER chaperone and cell death . CRT was translocated to the cell membrane of human leukemic cells treated with ZEA (Figure 7B). ER also regulates calcium ion homeostasis and Ca2+ levels were increased in cytosol and mitochondria, suggesting the involvement of ER stress in ZEA-treated human leukemic cells. 2D-PAGE of HL-60 treated cells showed increased expression of GRP78, ERp29 and CRT precursor confirming the existence of ER stress. Real-time reverse transcription PCR supported the involvement of ERp29 in the human leukemic HL-60 cell apoptosis. For CRT and GRP78 gene expression, the mRNA might not be stable and was degraded at the measured-time. Nevertheless, ER stress can also activate caspase-9 by releasing cytochrome c from mitochondria to cytosol [24, 25].
The accumulation of unfolded proteins in the ER was a marker of cellular stress induced by ZEA. Oxidative stress was also found in ZEA-stimulated human leukemic cell apoptosis (Figure 5). The involvement of ER stress and oxidative stress in ZEA-induced apoptosis of human leukemic cell lines are first described, however, further experiments are required to demonstrate the signaling relationship between the oxidative stress and ER stress.
The contents of ZEA in the daily intake might enhance the apoptotic effect of promyelocytic and monocytic leukemic cell lines in the leukemic patients. ZEA-induced apoptosis and necrosis occur in human PBMCs in vitro depending on the concentrations of ZEA . The major metabolites of ZEA in various species are alpha and beta zearalenol. Alpha and beta zearalenol inhibit cell viability and induce oxidative stress and stress protein (HSP70 and HSP27) expression in Vero cells (kidney epithelial cells extracted from African green monkey) . However, more studies should be performed in in vivo model before using ZEA as a therapeutic drug.
Taken together, the intrinsic (mitochondrial) and ER stress pathways cooperated in ZEA-induced human leukemic cell apoptosis. An understanding of the mechanism of ZEA-activated leukemic cell death is a basic step in clinical therapeutic approaches.
This work was financially supported by Thailand Research Fund (TRF) and Commission of Higher Education (CHE), grant No. RMU5080003. We thank Prof. Prapon Wilairat for editing the manuscript.
- Nikov G, Hopkins N, Boue S, Alworth WL: Interactions of dietary estrogens with human estrogen receptors and the effect on estrogen receptor-estrogen response element complex formation. Environ Health Perspect. 2000, 108: 867-872.PubMed CentralView ArticlePubMedGoogle Scholar
- Kuiper GG, Lemma JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JA: Interaction of estrogenic chemicals and phytoestrogens with estrogen receptors (beta). Endocrinology. 1998, 139: 4252-4263. 10.1210/en.139.10.4252.PubMedGoogle Scholar
- Janardhana GR, Rabeas KA, Shekar Shetty H: Mycotoxin contamination of maize grains grown in Karnataka (India). Food Chem Toxicol. 1999, 37: 863-868. 10.1016/S0278-6915(99)00067-8.View ArticlePubMedGoogle Scholar
- Okoye ZS: Stability of zearalenone in naturally contaminated corn during Nigerian traditional brewing. Food Addit Contam. 1987, 4: 57-59.View ArticlePubMedGoogle Scholar
- Reza Oveisi M, Hajimahmoodi M, Memarian S, Sadeghi N, Shoeibi S: Determination of zearalenone in corn flour and a cheese snack product using high-performance liquid chromatography with fluorescence detection. Food Addit Contam. 2005, 22: 443-448. 10.1080/02652030500073709.View ArticlePubMedGoogle Scholar
- Minervini F, Giannoccaro A, Cavallini A, Visconti A: Investigations on cellular proliferation induced by zearalenone and its derivatives in relation to the estrogenic parameters. Toxicol Lett. 2005, 159: 272-283. 10.1016/j.toxlet.2005.05.017.View ArticlePubMedGoogle Scholar
- Abid-Essefi S, Baudrimont I, Hassen W, Ouanes Z, Mobio TA, Anane R, Creppy EE, Bacha H: DNA fragmentation, apoptosis and cell cycle arrest induced by zearalenone in cultured DOK, Vero and Caco-2 cells: prevention by vitamin E. Toxicology. 2003, 192: 237-248. 10.1016/S0300-483X(03)00329-9.View ArticlePubMedGoogle Scholar
- Ayed-Boussema I, Bouaziz C, Rjiba K, Valenti K, Laporte F, Bacha H, Hassen W: The mycotoxin Zearalenone induces apoptosis in human hepatocytes (HepG2) via p53-dependent mitochondrial signaling pathway. Toxicol In Vitro. 2008, 22: 1671-1680. 10.1016/j.tiv.2008.06.016.View ArticlePubMedGoogle Scholar
- Dias N, Bailly C: Drugs targeting mitochondrial functions to control tumor cell growth. Biochem Pharmacol. 2005, 70: 1-12. 10.1016/j.bcp.2005.03.021.View ArticlePubMedGoogle Scholar
- Schulze-Osthoff K, Ferrari D, Los M, Wesselborg S, Peter M: Apoptosis signaling by death receptors. Eur J Biochem. 1998, 254: 439-459. 10.1046/j.1432-1327.1998.2540439.x.View ArticlePubMedGoogle Scholar
- Rao RV, Ellerby HM, Bredesen DE: Coupling endoplasmic reticulum stress to the cell death program. Cell Death Differ. 2004, 11: 372-380. 10.1038/sj.cdd.4401378.View ArticlePubMedGoogle Scholar
- Budihardjo I, Oliver H, Lutter M, Luo X, Wang X: Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol. 1999, 15: 269-290. 10.1146/annurev.cellbio.15.1.269.View ArticlePubMedGoogle Scholar
- Li UX, Kim CN, Yang J, Jemmerson R, Wang X: Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell. 1996, 86: 147-157. 10.1016/S0092-8674(00)80085-9.View ArticleGoogle Scholar
- Thorburn A: Death receptor-induced cell killing. Cell Signal. 2004, 16: 139-144. 10.1016/j.cellsig.2003.08.007.View ArticlePubMedGoogle Scholar
- Boyce M, Yuan J: Cellular response to endoplasmic reticulum stress: a matter of life or death. Cell Death Differ. 2006, 13: 363-373. 10.1038/sj.cdd.4401817.View ArticlePubMedGoogle Scholar
- Yamaguchi H, Wang HG: CHOP is involved in endoplasmic reticulum stress-induced apoptosis by enhancing DR5 expression in human carcinoma cells. J Biol Chem. 2004, 279: 45495-45502. 10.1074/jbc.M406933200.View ArticlePubMedGoogle Scholar
- Johnson S, Michalak M, Opas M, Eggleton P: The ins and outs of calreticulin: from the ER lumen to the extracellular space. Trends Cell Biol. 2001, 11: 122-129. 10.1016/S0962-8924(01)01926-2.View ArticlePubMedGoogle Scholar
- Michalak M, Corbett EF, Mesaeli N, Nakamura K, Opas M: Calreticulin: one protein, one gene, many functions. Biochem J. 1999, 344: 281-292. 10.1042/0264-6021:3440281.PubMed CentralView ArticlePubMedGoogle Scholar
- Gardai SJ, McPhillips KA, Frasch SC, Janssen WJ, Starefeldt A, Murphy-Ullrich JE: Cell surface calreticulin initiates clearance of viable or apoptotic cells through transactivation of LRP on the phagocyte. Cell. 2005, 123: 321-334. 10.1016/j.cell.2005.08.032.View ArticlePubMedGoogle Scholar
- Obeid M, Tesniere A, Ghringhelli F, Fimia GM, Apetoh L, Perfettini JL: Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med. 2007, 13: 54-61. 10.1038/nm1523.View ArticlePubMedGoogle Scholar
- Apetoh L, Ghringhelli F, Tesniere A, Obeid M, Ortiz C, Criolo A: Toll-like receptor 4-dependent contribution of the immune system to anti-cancer chemo- and radiotherapy. Nat Med. 2007, 13: 1050-1059. 10.1038/nm1622.View ArticlePubMedGoogle Scholar
- Casares N, Pequignot MO, Tesniere A, Ghringhelli F, Roux S, Chaput N: Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death. J Exp Med. 2005, 202: 1691-1701. 10.1084/jem.20050915.PubMed CentralView ArticlePubMedGoogle Scholar
- Srivastava PK: Heat shock protein-based novel immunotherapies. Drug News Perspect. 2000, 13: 517-522. 10.1358/dnp.2000.13.9.858479.View ArticlePubMedGoogle Scholar
- Momoi T: Caspases involved in ER stress-mediated cell death. J Chem Neuroanat. 2004, 28: 101-105.View ArticlePubMedGoogle Scholar
- Jimbo A, Fujita E, Kouroku Y, Ohnishi J, Inohara N, Kuida K, Sakamaki K, Yonchara S, Momoi T: ER stress induces caspase-8 activation, stimulating cytochrome c release and caspase-9 activation. Exp Cell Res. 2003, 283: 156-166. 10.1016/S0014-4827(02)00033-2.View ArticlePubMedGoogle Scholar
- Su WC, Chang SL, Chen TY, Chen JS, Tsao CJ: Comparison in in vitro growth-inhibitory activity of carboplatin and cisplatin on leukemic cells and hematopoietic progenitors: the myelosuppressive activity of carboplatin may be greater than its antileukemic effect. Jpn J Clin Oncol. 2002, 30: 562-567. 10.1093/jjco/hyd137.View ArticleGoogle Scholar
- Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001, 25: 402-408. 10.1006/meth.2001.1262.View ArticlePubMedGoogle Scholar
- Gottlieb E, Armour SM, Harris MH, Thompson CB: Mitochondrial membrane potential regulates matrix configuration and cytochrome c release. Cell Death Differ. 2003, 10: 709-717. 10.1038/sj.cdd.4401231.View ArticlePubMedGoogle Scholar
- Roucou X, Montessuit S, Antonsson B, Martinou JC: Bax oligomerization in mitochondrial membranes requires tBid (caspase-8-cleaved Bid) and a mitochondrial protein. Biochem J. 2002, 368: 915-921. 10.1042/BJ20020972.PubMed CentralView ArticlePubMedGoogle Scholar
- Scorrano L, Korsmeyer SJ: Mechanisms of cytochrome c release by proapoptotic BCL-2 family members. Biochem Biophys Res Commun. 2003, 304: 437-444. 10.1016/S0006-291X(03)00615-6.View ArticlePubMedGoogle Scholar
- Korsmeyer SJ, Wei MC, Saito M, Weiler S, Oh KJ, Schlesinger PH: Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c. Cell Death Differ. 2000, 7: 1166-1173. 10.1038/sj.cdd.4400783.View ArticlePubMedGoogle Scholar
- Bouaziz C, Sharaf El Dein O, El Golli E, Abid-Essefi S, Brenner C, Lemaire C: Different apoptotic pathways induced by zearalenone, T-2 toxin and ochratoxin A in human hepatoma cells. Toxicology. 2008, 254: 19-28. 10.1016/j.tox.2008.08.020.View ArticlePubMedGoogle Scholar
- Bizyukin AV, Korkina LG, Velichkovskii BT: Comparative Use of 2,7-dichlorofluorescin diacetate, dihydrorhodamine 123, and hydroethidine to study oxidative metabolism in phagocytic cells. Bull Eksp Biol Med. 1995, 119: 347-351. 10.1007/BF02445889.View ArticleGoogle Scholar
- Silveira LR, Pereira-Da-Silva L, Juel C, Hellsten Y: Formation of hydrogen peroxide and nitric oxide in rat skeletal muscle cells during contractions. Free Radic Biol Med. 2003, 35: 455-464. 10.1016/S0891-5849(03)00271-5.View ArticlePubMedGoogle Scholar
- Picard D: Heat-shock protein 90, a chaperone for folding and regulation. Cell Mol Life Sci. 2002, 59: 1640-1648. 10.1007/PL00012491.View ArticlePubMedGoogle Scholar
- Zhang D, Armstrong JS: Bax and the mitochondrial permeability transition cooperate in the release of cytochrome c during endoplasmic reticulum-stress-induced apoptosis. Cell Death Differ. 2007, 14: 703-715. 10.1038/sj.cdd.4402072.View ArticlePubMedGoogle Scholar
- Tufi R, Panaretakis T, Bianchi K, Criollo A, Fazi B, Di Sano F, Tesniere A, Kepp O, Paterlini-Brechot P, Zitvogel L, Piacentini M, Szabadkai G, Kroemer G: Reduction of endoplasmic reticulum calcium ion levels favors plasma membrane surface exposure of calreticulin. Cell Death Differ. 2007, 14: 1-9. 10.1038/sj.cdd.4402064.View ArticleGoogle Scholar
- D'Mello JPF, Placinta CM, MacDonald AMC: Fusarium mycotoxins: a review of global animal health, welfare and reproductivity. Anim Feed Sci Technol. 1999, 78: 183-205.View ArticleGoogle Scholar
- Minervini F, Dell'Aquila ME, Maritato F, Minoia P, Visconti A: Toxic effects of the mycotoxin zearalenone and its derivatives on in vitro maturation of bovine oocytes and 17[beta]-estradiol levels in mural granulosa cell cultures. Toxicol In Vitro. 2001, 15: 489-495. 10.1016/S0887-2333(01)00068-6.View ArticlePubMedGoogle Scholar
- Lioi MB, Santoro A, Barbieri R, Salzano S, Ursini MV: Ochratoxin A and zearalenone: a comparative study on genotoxic effects and cell death induced in bovine lymphocytes. Mutat Res. 2004, 557: 19-27.View ArticlePubMedGoogle Scholar
- Vlata Z, Porichis F, Tzanakakis G, Tsatsakis A, Krambovitis E: A study of zearalenone cytotoxicity on human peripheral blood mononuclear cells. Toxicol Lett. 2006, 165: 274-281. 10.1016/j.toxlet.2006.05.001.View ArticlePubMedGoogle Scholar
- Kouadio JH, Mobio TA, Baudrimont I, Moukha S, Dano SD, Creppy EE: Comparative study of cytotoxicity and oxidative stress induced by deoxynivalenol, zearalenone or fumonisin B1 in human intestinal cell line Caco-2. Toxicology. 2005, 213: 56-65. 10.1016/j.tox.2005.05.010.View ArticlePubMedGoogle Scholar
- Jürgensmeier JM, Xie Z, Deveraux Q, Ellerby L, Bredesen D, Reed J: Bax directly induces release of cytochrome c from isolated mitochondria. Proc Natl Acad Sci USA. 1998, 95: 4997-5002.PubMed CentralView ArticlePubMedGoogle Scholar
- Antonsson B, Montessuit S, Lauper S, Eskes R, Martinou JC: Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mitochondria. Biochem J. 2000, 345: 271-278. 10.1042/0264-6021:3450271.PubMed CentralView ArticlePubMedGoogle Scholar
- Yang JC, Cortopassi GA: Induction of the mitochondrial permeability transition causes release of the apoptogenic factor cytochrome c. Free Radic Biol Med. 1998, 24: 624-631. 10.1016/S0891-5849(97)00367-5.View ArticlePubMedGoogle Scholar
- Bradham CA, Qian T, Streetz K, Trautwein C, Brenner DA, Lemasters JJ: The mitochondrial permeability transition is required for tumor necrosis factor alpha-mediated apoptosis and cytochrome c release. Mol Cell Biol. 1998, 18: 6353-6364.PubMed CentralView ArticlePubMedGoogle Scholar
- Hara MR, Agrawal N, Kim SF, Cascio MB, Fujimuro M, Ozeki Y, Takahashi M, Cheah MJH, Tankou SK, Hester LD, Ferris CD, Hayward SD, Snyder SH, Sawa A: S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding. Nat Cell Biol. 2005, 7: 665-674. 10.1038/ncb1268.View ArticlePubMedGoogle Scholar
- Munro S, Pelham HR: A C-terminal signal prevents secretion of luminal ER proteins. Cell. 1987, 48: 899-907. 10.1016/0092-8674(87)90086-9.View ArticlePubMedGoogle Scholar
- Pelham HR: Evidence that luminal ER proteins are sorted from secreted proteins in a post-ER compartment. EMBO J. 1988, 7: 913-918.PubMed CentralPubMedGoogle Scholar
- Xu C, Bailly-Maitre B, Reed JC: Endoplasmic reticulum stress: cell life and death decision. J Clin Invest. 2005, 115: 2656-2664. 10.1172/JCI26373.PubMed CentralView ArticlePubMedGoogle Scholar
- Othmen ZO, Golli EE, Abid-Essefi S, Bacha H: Cytotoxicity effects induced by Zearalenone metabolites, alpha Zearalenol and beta Zearalenol, on cultured Vero cells. Toxicology. 2008, 252: 72-77. 10.1016/j.tox.2008.07.065.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<url>http://creativecommons.org/licenses/by/2.0</url>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.